Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Legal and General pre-tax profits grow in 'excellent' H1

(Sharecast News) - Insurance firm Legal & General said on Tuesday that it had an "excellent" six months ended 30 June, with both pre-tax and core operating profits growing, underpinned by strategic progress and a reshaped portfolio. Core operating profits rose 6% to £859m, while IFRS pre-tax profits surged 28% to £406m, buoyed by a strong performance in its institutional retirement segment, which saw double-digit profit growth and over £5bn in new business written.

Legal & General highlighted that its asset management division had delivered £15m in annualised net new revenue, lifting margins to 9 basis points, even as operating profits fell from £214m to £202m, while its retail unit saw workplace pension assets top £100bn, with net new flows up 21% year-on-year to £4bn and operating profits increasing 3% to £237m.

The FTSE 100-listed firm also noted that its solvency ratio was steady at 217% and net debt had fallen from £4.71bn to £3.39bn. It also declared an interim dividend per share of 6.12p, up 2% in line with guidance.

Chief executive António Simões said: "We are growing and making the most of the synergies between our three businesses. Institutional Retirement operating profit is up double digits, and we have written over £5bn of new business at low capital strain.

"The outlook for our businesses is positive and we are firmly on track to achieve our financial targets. We are delivering on our promise to return more to shareholders with over £5bn in dividends and share buybacks over three years."

Reporting by Iain Gilbert at Sharecast.com

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.